Macular Pigment Optical Density (MPOD) Tester
Beginning on Thursday, November 3rd, our practice will be adding a Macular Pigment Optical Density (MPOD) tester from ZeaVision. This new technology will allow us to measure the amount of pigment level in the eyes. The thickness or the density of the macular pigment varies from person to person. The density can also change over time depending on several factors such as aging, lifestyle and dietary choices. Do you know your pigment level? If your pigment is low, you are at an increased risk for Age-Related Macular Degeneration (ARM). A healthy macular pigment is essential for your vision because it helps to absorb harmful blue light, protecting photo-receptors from damage. A dense macular pigment is important to keep your vision as crisp as possible. The good news is that your macular pigment can be increased with the right diet and supplements.
Age-Related Macular Degeneration is the number one leading cause of blindness in adults. Early detection and careful monitoring of your vision are the best methods to prevent vision changes from macular degeneration. Getting your vision checked on an annual basis will help prevent ARM and the vision problem may be easier to treat. The MPOD tester has been proven to be the most reliable and accurate device for measuring pigment ocular density. Patients can stop by anytime on November 3rd to have their pigment level checked for free. After this date, the tester will still be free; however, an appointment will be necessary. For more information or to schedule an appointment with one of our doctors, call our Technical Director, Paige, at 615-771-7555.
Posted on 10/26/2016 8:56 AM by Dr. Jeffrey Kegarise
Xiidra - New Medication for Dry Eye Disease
Recently, Shire pharmaceuticals released Xiidra to reduce the inflammatory component of chronic dry eye. More than 30 million Americans suffer with this painful condition. Xiidra, also called lifitegrast, is the first medication in over 16 years to be released and approved by the FDA to treat the signs and symptoms of dry eye disease. Patients with dry eye disease, DED, often have symptoms which range from blurred vision to painful eyes. Xiidra has been approved to not only improve the clinical signs of dry eye, but also to provide relief for these frustrating patient symptoms in as little as two weeks. The most common side effect of the medication is dysgeusiaâ€¦which is another way of saying most users have an unusual aftertaste.
While the medication can be costly, many insurance plans are adding Xiidra to their formulary and rebates are available to reduce patient co-pays. DED has many causes and for most patients, one treatment does not treat all signs and symptoms. We believe Xiidra will be an additive tool to improve our patients' long term ocular health and reduce the pain associated with chronic dry eye.
If you have any additional questions on this new medication, please call Melissa at 615-771-7555 to set up an appointment in our Dry Eye Clinic.
Posted on 10/07/2016 10:56 AM by Dr. Jeffrey Kegarise